York M - Search Results

1

Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.

Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Hunter DJ, et al. Among authors: york m. J Rheumatol. 2006 Jul;33(7):1341-5. Epub 2006 Jun 1. J Rheumatol. 2006. PMID: 16758506

2

Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone.

York M, Hunter DJ. York M, et al. ACP J Club. 2006 May-Jun;144(3):72. ACP J Club. 2006. PMID: 16646616 No abstract available.

3

Pulmonary hypertension: screening and evaluation in scleroderma.

York M, Farber HW. York M, et al. Curr Opin Rheumatol. 2011 Nov;23(6):536-44. doi: 10.1097/BOR.0b013e32834ba6a7. Curr Opin Rheumatol. 2011. PMID: 21934501 Review.

4

Innate immunity and inflammation in systemic sclerosis.

Lafyatis R, York M. Lafyatis R, et al. Among authors: york m. Curr Opin Rheumatol. 2009 Nov;21(6):617-22. doi: 10.1097/BOR.0b013e32832fd69e. Curr Opin Rheumatol. 2009. PMID: 19633559 Free PMC article. Review.

5

Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis.

Kissin EY, Garg A, Grayson PC, Dubreuil M, Vradii D, York M, Simms RW. Kissin EY, et al. Among authors: york m. J Clin Rheumatol. 2013 Oct;19(7):382-5. doi: 10.1097/RHU.0000000000000020. J Clin Rheumatol. 2013. PMID: 24048117

6

A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.

York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. York MR, et al. Arthritis Rheum. 2007 Mar;56(3):1010-20. doi: 10.1002/art.22382. Arthritis Rheum. 2007. PMID: 17328080 Free article.

7

Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.

Farina GA, York MR, Di Marzio M, Collins CA, Meller S, Homey B, Rifkin IR, Marshak-Rothstein A, Radstake TR, Lafyatis R. Farina GA, et al. Among authors: york mr. J Invest Dermatol. 2010 Nov;130(11):2583-93. doi: 10.1038/jid.2010.200. Epub 2010 Jul 8. J Invest Dermatol. 2010. PMID: 20613770 Free PMC article.

8

Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.

van Bon L, Popa C, Huijbens R, Vonk M, York M, Simms R, Hesselstrand R, Wuttge DM, Lafyatis R, Radstake TR. van Bon L, et al. Among authors: york m. Ann Rheum Dis. 2010 Aug;69(8):1539-47. doi: 10.1136/ard.2009.128207. Epub 2010 May 24. Ann Rheum Dis. 2010. PMID: 20498209

9

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel PA, Simms RW. Lafyatis R, et al. Among authors: york m. Arthritis Rheum. 2009 Feb;60(2):578-83. doi: 10.1002/art.24249. Arthritis Rheum. 2009. PMID: 19180481 Free PMC article. Clinical Trial.

10

dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.

Farina G, York M, Collins C, Lafyatis R. Farina G, et al. Among authors: york m. Ann Rheum Dis. 2011 Mar;70(3):544-50. doi: 10.1136/ard.2010.132464. Epub 2010 Nov 10. Ann Rheum Dis. 2011. PMID: 21068089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters